Logo image of AXON

AXON ENTERPRISE INC (AXON) Stock Fundamental Analysis

USA - NASDAQ:AXON - US05464C1018 - Common Stock

774.53 USD
+8.06 (+1.05%)
Last: 9/19/2025, 8:00:01 PM
773.01 USD
-1.52 (-0.2%)
After Hours: 9/19/2025, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, AXON scores 5 out of 10 in our fundamental rating. AXON was compared to 69 industry peers in the Aerospace & Defense industry. AXON has an average financial health and profitability rating. AXON is valued quite expensively, but it does show have an excellent growth rating. These ratings could make AXON a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year AXON was profitable.
AXON had a positive operating cash flow in the past year.
In multiple years AXON reported negative net income over the last 5 years.
AXON had a positive operating cash flow in each of the past 5 years.
AXON Yearly Net Income VS EBIT VS OCF VS FCFAXON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 5.25%, AXON is doing good in the industry, outperforming 71.01% of the companies in the same industry.
AXON has a better Return On Equity (11.94%) than 79.71% of its industry peers.
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROIC N/A
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
AXON Yearly ROA, ROE, ROICAXON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

AXON has a Profit Margin of 13.64%. This is amongst the best in the industry. AXON outperforms 88.41% of its industry peers.
In the last couple of years the Profit Margin of AXON has grown nicely.
The Gross Margin of AXON (60.47%) is better than 91.30% of its industry peers.
In the last couple of years the Gross Margin of AXON has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 13.64%
GM 60.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
AXON Yearly Profit, Operating, Gross MarginsAXON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

6

2. Health

2.1 Basic Checks

AXON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXON has more shares outstanding
The number of shares outstanding for AXON has been increased compared to 5 years ago.
AXON has a better debt/assets ratio than last year.
AXON Yearly Shares OutstandingAXON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXON Yearly Total Debt VS Total AssetsAXON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 11.45 indicates that AXON is not in any danger for bankruptcy at the moment.
AXON's Altman-Z score of 11.45 is amongst the best of the industry. AXON outperforms 89.86% of its industry peers.
AXON has a debt to FCF ratio of 11.38. This is a negative value and a sign of low solvency as AXON would need 11.38 years to pay back of all of its debts.
With a Debt to FCF ratio value of 11.38, AXON perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that AXON is somewhat dependend on debt financing.
AXON's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. AXON is outperformed by 62.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Altman-Z 11.45
ROIC/WACCN/A
WACC9.73%
AXON Yearly LT Debt VS Equity VS FCFAXON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.95 indicates that AXON has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.95, AXON is doing good in the industry, outperforming 63.77% of the companies in the same industry.
AXON has a Quick Ratio of 2.71. This indicates that AXON is financially healthy and has no problem in meeting its short term obligations.
AXON has a Quick ratio of 2.71. This is amongst the best in the industry. AXON outperforms 81.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.95
Quick Ratio 2.71
AXON Yearly Current Assets VS Current LiabilitesAXON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

8

3. Growth

3.1 Past

AXON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.24%, which is quite impressive.
The Earnings Per Share has been growing by 41.41% on average over the past years. This is a very strong growth
AXON shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.37%.
The Revenue has been growing by 31.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%

3.2 Future

The Earnings Per Share is expected to grow by 19.51% on average over the next years. This is quite good.
Based on estimates for the next years, AXON will show a quite strong growth in Revenue. The Revenue will grow by 19.50% on average per year.
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue Next Year30.95%
Revenue Next 2Y27.6%
Revenue Next 3Y25.4%
Revenue Next 5Y19.5%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXON Yearly Revenue VS EstimatesAXON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
AXON Yearly EPS VS EstimatesAXON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

AXON is valuated quite expensively with a Price/Earnings ratio of 109.71.
AXON's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of AXON to the average of the S&P500 Index (27.38), we can say AXON is valued expensively.
Based on the Price/Forward Earnings ratio of 95.90, the valuation of AXON can be described as expensive.
Based on the Price/Forward Earnings ratio, AXON is valued a bit more expensive than 60.87% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AXON to the average of the S&P500 Index (22.86), we can say AXON is valued expensively.
Industry RankSector Rank
PE 109.71
Fwd PE 95.9
AXON Price Earnings VS Forward Price EarningsAXON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXON is valued a bit more expensive than 65.22% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXON is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 344.5
EV/EBITDA 982.51
AXON Per share dataAXON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AXON's earnings are expected to grow with 19.51% in the coming years.
PEG (NY)6.73
PEG (5Y)2.65
EPS Next 2Y17.2%
EPS Next 3Y19.51%

0

5. Dividend

5.1 Amount

No dividends for AXON!.
Industry RankSector Rank
Dividend Yield N/A

AXON ENTERPRISE INC

NASDAQ:AXON (9/19/2025, 8:00:01 PM)

After market: 773.01 -1.52 (-0.2%)

774.53

+8.06 (+1.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners81.96%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner Change5.24%
Market Cap60.80B
Analysts83.08
Price Target885.54 (14.33%)
Short Float %2.19%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.34%
Min EPS beat(2)8.51%
Max EPS beat(2)42.17%
EPS beat(4)4
Avg EPS beat(4)28.65%
Min EPS beat(4)8.51%
Max EPS beat(4)45.27%
EPS beat(8)8
Avg EPS beat(8)26.23%
EPS beat(12)12
Avg EPS beat(12)33.52%
EPS beat(16)16
Avg EPS beat(16)60.63%
Revenue beat(2)2
Avg Revenue beat(2)2.58%
Min Revenue beat(2)1.38%
Max Revenue beat(2)3.78%
Revenue beat(4)3
Avg Revenue beat(4)1.6%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)3.78%
Revenue beat(8)7
Avg Revenue beat(8)2.04%
Revenue beat(12)11
Avg Revenue beat(12)3.55%
Revenue beat(16)15
Avg Revenue beat(16)4.85%
PT rev (1m)9.21%
PT rev (3m)22.37%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)8.39%
EPS NY rev (3m)9.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.18%
Revenue NY rev (1m)2.1%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 109.71
Fwd PE 95.9
P/S 25.42
P/FCF 344.5
P/OCF 220.63
P/B 22.25
P/tB 33.64
EV/EBITDA 982.51
EPS(TTM)7.06
EY0.91%
EPS(NY)8.08
Fwd EY1.04%
FCF(TTM)2.25
FCFY0.29%
OCF(TTM)3.51
OCFY0.45%
SpS30.47
BVpS34.81
TBVpS23.03
PEG (NY)6.73
PEG (5Y)2.65
Profitability
Industry RankSector Rank
ROA 5.25%
ROE 11.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.64%
GM 60.47%
FCFM 7.38%
ROA(3y)6.24%
ROA(5y)3.01%
ROE(3y)12.89%
ROE(5y)6.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.99%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
F-Score4
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 11.38
Debt/EBITDA 29.12
Cap/Depr 163.86%
Cap/Sales 4.14%
Interest Coverage N/A
Cash Conversion 464.18%
Profit Quality 54.09%
Current Ratio 2.95
Quick Ratio 2.71
Altman-Z 11.45
F-Score4
WACC9.73%
ROIC/WACCN/A
Cap/Depr(3y)192.5%
Cap/Depr(5y)286.11%
Cap/Sales(3y)4.12%
Cap/Sales(5y)5.78%
Profit Quality(3y)94.26%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.24%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%76.67%
EPS Next Y16.3%
EPS Next 2Y17.2%
EPS Next 3Y19.51%
EPS Next 5YN/A
Revenue 1Y (TTM)32.37%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%32.62%
Revenue Next Year30.95%
Revenue Next 2Y27.6%
Revenue Next 3Y25.4%
Revenue Next 5Y19.5%
EBIT growth 1Y-100.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.57%
EBIT Next 3Y48.75%
EBIT Next 5YN/A
FCF growth 1Y59.92%
FCF growth 3Y64.36%
FCF growth 5Y46.2%
OCF growth 1Y74.03%
OCF growth 3Y48.58%
OCF growth 5Y44.12%